Mini-Focus Issue: Stent Thrombosis and Platelet ReactivityClinical ResearchA Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty–Platelet Reactivity for Outcome Validation Effort) Study
Clinical Research
Under an Elsevier user license
open archive
Key Words
clopidogrel
percutaneous coronary intervention
platelet function test
Abbreviations and Acronyms
AUC
area under the curve
CI
confidence interval
HPR
high platelet reactivity
LPR
low platelet reactivity
MI
myocardial infarction
NACE
net adverse clinical event(s)
NPR
normal platelet reactivity
NPV
negative predictive value
OR
odds ratio
PCI
percutaneous coronary intervention
PPV
positive predictive value
PRU
P2Y12 reaction units
ROC
receiver-operating characteristic
ST
stent thrombosis
TIMI
Thrombolysis In Myocardial Infarction
TVR
target vessel revascularization
Cited by (0)
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.